Kathleen DeRose - Oct 31, 2021 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Director
Signature
/s/ Blake Nielsen, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Oct 31, 2021
Transactions value $
$0
Form type
4
Date filed
11/2/2021, 06:09 PM
Previous filing
Oct 21, 2021
Next filing
May 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +11K $0.00 11K Oct 31, 2021 Direct F1
transaction ENFN Class A Common Stock Award $0 +5.52K +50% $0.00 16.5K Oct 31, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The restricted stock units vest as follows: 3,676 RSUs on September 27, 2022; 3,676 RSUs on September 27, 2023; and 3,677 RSUs on September 27, 2024.
F2 Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The restricted stock units will vest in full on the date of the 2022 annual meeting of stockholders of the issuer.